Agentis Longevity learned that the FDA's Pharmacy Compounding Advisory Committee has recommended BPC-157, TB-500, and other peptides for the compounding bulk list.
Public source
Publisher name
Public post
The FDA's Pharmacy Compounding Advisory Committee has recommended BPC-157, TB-500, and other peptides for the compounding bulk list. That's not FDA approval of a new dru…
Company
Agentis Longevity
Where best in class longevity care meets best in class partnerships.
- Industry
- Health and Human Services
- Location
- Nashville, US
- Company size
- 11–50 employees
About Agentis Longevity
Agentis Longevity is a clinically focused provider of comprehensive longevity care — including advanced diagnostics, hormone optimization, and innovative anti-aging therapies. Our mission is to help patients take a proactive approach to their health, advancing longer, healthier, happier lives. We’re building a leading national platform by partnering with top-tier providers and driving growth through strategic marketing and new clinic openings. Our centralized support model empowers clinics to deliver exceptional care by providing resources in operations, finance, marketing, and clinical leadership via a dedicated Medical Advisory Board. We believe we as Agentis are uniquely positioned to become the clinical lea Integrity in Practice: We uphold the highest standards by proactively seeking solutions to improve lives. By shifting from a reactive to a preventative healthcare model, we ensure our actions consistently meet our patients’ needs. Mission for Excellence: Excellence is at the heart of everything we do, driving us to achieve peak performance. We are committed to continuously advancing health and wellness, always striving for the next level. Passion for Impact: We believe in taking an active role in one’s own well-being to drive breakthroughs. By focusing on quality outcomes, we provide hope and lasting health that leads to life-changing impacts for our patients. Accessibility: We make the transformative power of health accessible to patients nationwide, ensuring their needs are met as they take control of their well-being. By providing resources, guidance, affordability, and transparency, we empower patients to live longer and live well as they age. Clinical Quality: We focus on continuous improvement through innovation. We set the benchmark for Industry leading-quality, patient-centered care. Teamwork: By working together, we create comprehensive solutions that address the diverse needs of our patients, driving better outcomes and a stronger impact.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Products & Services
Lifespanning
Lifespanning launched the LifespanningRx Peptide Explorer to support informed, clinician-guided therapy discussions.
Research & Knowledge
Biolongevity
Biolongevity published an article breaking down evidence tiers behind compounds for inflammation, including KPV, BPC-157, GHK-Cu, thymus-derived peptides, PEA, and Urolithin A.
Research & Knowledge
Biohack Yourself Media
Biohack Yourself Media published an article exploring the manufacturing standards behind research-grade peptides, emphasizing U.S.-based synthesis, cGMP-compliant and NSF-certified manufacturing, batch-specific Certificates of Analysis, and a supply chain that does not rely on Chinese API sourcing.
Legal & Regulatory
Scientech Laboratories, LLC
Scientech Laboratories, LLC reported that the FDA advisory committee voted to recommend approval of seven additional peptide products for the 503A bulks list drugs including BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax.
Research & Knowledge
GlobalData Healthcare